Compare stocks

AB Science S.A. is a biotechnology company based in Paris, France, specializing in the research, development, and commercialization of protein kinase inhibitors. These are used in the treatment of cancers, chronic inflammatory diseases, and neurodegenerative disorders. Established in 2001, the company targets diseases with significant unmet medical needs through proprietary compounds, notably masitinib which is in various stages of clinical trials. AB Science operates primarily in Europe and has various products in its pipeline aimed at both human and veterinary medicine. Its strategic focus on niche therapeutic areas where there are few treatment options gives it a distinct position in the pharmaceutical industry.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.